Author:
Albertsmeier Markus,Stintzing Sebastian,Guba Markus,Werner Jens,Angele Martin
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Schlesinger-Raab, A., et al. Versorgungsforschung: Kolorektales Karzinom. Evaluation der Versorgung von Darmkrebspatienten im Einzugsgebiet des Tumorregisters München (TRM) auf der Basis der aktuellen S3-Leitlinie 2012.
2. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., AWMF) S3-Leitlinie Kolorektales Karzinom, Langversion 1.1, AWMF Registrierungsnummer: 021-007OL. 2014.
3. Jones, R.P., et al., Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg, 2012. 99(9): p. 1263–9.
4. Folprecht, G., et al., Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol, 2010. 11(1): p. 38–47.
5. Heinemann, V., et al., FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol, 2014. 15(10): p. 1065–75.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献